| Trial Identifier: | 8374-CL-0101 |
| Sponsor: | Astellas Pharma Global Development, Inc. |
| Collaborator: |
Merck & Co., Inc.
|
| Start Date: | September 2017 |
| Primary Completion Date: | May 2022 |
| Study Completion Date: | May 2022 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Country | Location |
|---|---|
| Canada, Alberta | Edmonton, Alberta, Canada, T6G 1Z2 |
| Canada, ON | Toronto, ON, Canada, M5G 2M9 |
| Canada, ON | Toronto, ON, Canada, M4N 3M5 |
| Canada, Quebec | Montreal, Quebec, Canada, H3T 1E2 |
| Italy | Ancona, Italy |
| Italy | Meldola, Italy |
| Italy | Milano, Italy |
| Italy | Modena, Italy |
| Italy | Monza, Italy |
| Italy | Negrar, Italy |
| Italy | Pisa, Italy |
| Italy | Siena, Italy |
| Japan | Chuo-ku, Japan |
| Korea (Republic of) | Seoul, Korea (Republic of) |
| Korea (Republic of) | Seoul, Korea (Republic of), 120-752 |
| Korea (Republic of) | Seoul, Korea (Republic of), 03080 |
| Korea (Republic of), Gyeonggi-do | Goyang-si, Gyeonggi-do, Korea (Republic of), 410-769 |
| Korea (Republic of), Gyeonggi-do | Seongnam-Si, Gyeonggi-do, Korea (Republic of), 013620 |
| Portugal | Lisboa, Portugal |
| Portugal | Porto, Portugal |
| Spain | Barcelona, Spain |
| Spain | Madrid, Spain |
| Spain | Valencia, Spain |
| Taiwan, Province of China | Taichung, Taiwan, Province of China, 00404 |
| Taiwan, Province of China | Tainan, Taiwan, Province of China |
| Taiwan, Province of China | Taipei City, Taiwan, Province of China |
| United Kingdom | Leeds, United Kingdom |
| United Kingdom | London, United Kingdom |
| United Kingdom | Newcastle upon Tyne, United Kingdom |
| United Kingdom | Sutton Surry, United Kingdom |
| United States of America, Arizona | Tucson, Arizona, United States of America, 85719 |
| United States of America, AZ | Scottsdale, AZ, United States of America, 85258 |
| United States of America, CA | Los Angeles, CA, United States of America, 90048 |
| United States of America, CA | Los Angeles, CA, United States of America, 90095 |
| United States of America, CA | Sacramento, CA, United States of America, 95817 |
| United States of America, CA | San Francisco, CA, United States of America, 94115 |
| United States of America, FL | Miami Beach, FL, United States of America, 33140 |
| United States of America, IA | Iowa City, IA, United States of America, 52242 |
| United States of America, KS | Fairway, KS, United States of America, 66205 |
| United States of America, MI | Detroit, MI, United States of America, 48201 |
| United States of America, MI | Detroit, MI, United States of America, 48202 |
| United States of America, NC | Chapel Hill, NC, United States of America, 27599 |
| United States of America, NY | New York, NY, United States of America, 10032 |
| United States of America, NY | New York, NY, United States of America, 10029 |
| United States of America, Ohio | Cleveland, Ohio, United States of America, 44106 |
| United States of America, PA | Philadelphia, PA, United States of America, 19111 |
| United States of America, PA | Pittsburgh, PA, United States of America, 15232 |
| United States of America, TN | Nashville, TN, United States of America, 37203 |
| United States of America, TX | Dallas, TX, United States of America, 75251 |
| United States of America, UT | Salt Lake City, UT, United States of America, 84112 |
| United States of America, VA | Fairfax, VA, United States of America, 22031 |
| United States of America, WI | Milwaukee, WI, United States of America, 53226-3522 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company